Works matching IS 15272729 AND DT 2022 AND VI 23 AND IP 2

Results: 11

The TRIM proteins in cancer: from expression to emerging regulatory mechanisms.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 460, doi. 10.1007/s12094-021-02715-5

By:

Mohammadi, A.;
Pour Abbasi, M. S.;
Khorrami, S.;
Khodamoradi, S.;
Mohammadi Goldar, Z.;
Ebrahimzadeh, F.

Publication type:

Article

Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 432, doi. 10.1007/s12094-021-02709-3

By:

Hazafa, A.;
Iqbal, M. O.;
Javaid, U.;
Tareen, M. B. K.;
Amna, D.;
Ramzan, A.;
Piracha, S.;
Naeem, M.

Publication type:

Article

Low-dose radiation therapy for hand osteoarthritis: shaking hands again?

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 532, doi. 10.1007/s12094-021-02710-w

By:

Álvarez, B.;
Montero, A.;
Alonso, R.;
Valero, J.;
López, M.;
Ciérvide, R.;
Sánchez, E.;
Hernando, O.;
García-Aranda, M.;
Martí, J.;
Prado, A.;
Chen-Zhao, X.;
Rubio, C.

Publication type:

Article

Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 483, doi. 10.1007/s12094-021-02708-4

By:

García-Alfonso, P.;
Saiz-Rodríguez, M.;
Mondéjar, R.;
Salazar, J.;
Páez, D.;
Borobia, A. M.;
Safont, M. J.;
García-García, I.;
Colomer, R.;
García-González, X.;
Herrero, M. J.;
López-Fernández, L. A.;
Abad-Santos, F.

Publication type:

Article

Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 471, doi. 10.1007/s12094-021-02716-4

By:

Wei, J.;
Liu, Z.;
He, J.;
Liu, Q.;
Lu, Y.;
He, S.;
Yuan, B.;
Zhang, J.;
Ding, Y.

Publication type:

Article

Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 556, doi. 10.1007/s12094-021-02714-6

By:

Kim, H.;
Heo, Y. J.;
Cho, Y. A.;
Kang, S. Y.;
Ahn, S.;
Kim, K. -M.

Publication type:

Article

MiR-590 suppresses the progression of non-small cell lung cancer by regulating YAP1 and Wnt/β-catenin signaling.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 546, doi. 10.1007/s12094-021-02713-7

By:

Hao, X.;
Su, A.

Publication type:

Article

Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 446, doi. 10.1007/s12094-021-02712-8

By:

Guirado, M.;
Sanchez-Hernandez, A.;
Pijuan, L.;
Teixido, C.;
Gómez-Caamaño, A.;
Cilleruelo-Ramos, Á.

Publication type:

Article

Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 407, doi. 10.1007/s12094-021-02707-5

By:

Murali, M.;
Kumar, A. R.;
Nair, B.;
Pavithran, K.;
Devan, A. R.;
Pradeep, G. K.;
Nath, L. R.

Publication type:

Article

Circulating exosomal miRNAs and cancer early diagnosis.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 393, doi. 10.1007/s12094-021-02706-6

By:

Zhu, L.;
Zhao, L.;
Wang, Q.;
Zhong, S.;
Guo, X.;
Zhu, Y.;
Bao, J.;
Xu, K.;
Liu, S.

Publication type:

Article

Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case–control study.

Published in:

Current Treatment Options in Oncology, 2022, v. 23, n. 2, p. 540, doi. 10.1007/s12094-021-02711-9

By:

Chen, Can;
Li, Yiwei;
Yu, Jingdi;
Qian, Shenxian

Publication type:

Article